(Technische Universitaet Muenchen) Based on a high throughput screening of a substance library biochemists at the Technische Universitaet Muenchen have identified the lead structure of a new class of drugs that reversibly blocks the proteasome by a previously unknown binding mechanism.
New medication not only against cancer could be developed on the basis of this new mechanism. The "Early View" of the international edition of Angewandte Chemie reports on their results.